Large numbers of armed forces personnel returning from southwest Asia may present with infections that are not endemic to the United States or that occur rarely and are underdiagnosed in the United States. We report 2 cases of acute Q fever in members of the US Military recently returned from Iraq. Because a number of recent reports suggest that the risk of Q fever may be higher than initially thought among US forces deployed to this region, clinicians need to have a high index of clinical suspicion, an understanding of the available diagnostic tests, and knowledge regarding the methodology and capabilities of the laboratory to which specimens are submitted. Two weeks after his return from Iraq, he developed sore throat, fever (temperatures to 39.2ЊC), myalgia, chills, sweats, headache, and anorexia. He was seen in a primary care clinic on 2 occasions, received a diagnosis of a viral syndrome, and was treated with naprosyn. His only other medication was rabeprazole for gastroesophageal reflux disease. One week after the onset of symptoms, he developed a fever (temperature to 40ЊC) and became listless. His wife took him to the nearest emergency department (at an outside facility), and he was subsequently admitted to the hospital.
manifestations of infection with this organism, but a 2004 report described 102 patients with A. baumannii bacteremia admitted to military medical treatment facilities [2] . Nosocomial transmission of this organism within the Walter Reed Army Medical Center (Washington, DC) resulted in 53 infections, including 4 infections resulting in death [1] . Relatively little is known about the frequency with which US forces in southwest Asia are developing other infections, such as Q fever.
Case report 1. In September 2003, a 39-year-old male member of the US Army was evaluated in the Infectious Diseases Clinic at David Grant US Air Force Medical Center (Travis Air Force Base, CA) for a resolved febrile illness. He had been deployed to Iraq from April to July of 2003. While in Iraq, he lived and ate in the community. The house in which he lived bordered on what had once been a large sheep farm, and sheep carcasses were still present in the area. The farewell party that his Iraqi friends threw for him included the ceremonial slaughter of a sheep. He started weekly mefloquine therapy 2 weeks prior to entering Iraq, but stopped therapy 2 weeks prior to his return to the United States.
Two weeks after his return from Iraq, he developed sore throat, fever (temperatures to 39.2ЊC), myalgia, chills, sweats, headache, and anorexia. He was seen in a primary care clinic on 2 occasions, received a diagnosis of a viral syndrome, and was treated with naprosyn. His only other medication was rabeprazole for gastroesophageal reflux disease. One week after the onset of symptoms, he developed a fever (temperature to 40ЊC) and became listless. His wife took him to the nearest emergency department (at an outside facility), and he was subsequently admitted to the hospital.
The findings of a physical examination were remarkable for fever and tachycardia. Pertinent negative findings included no adenopathy, no abnormalities on lung auscultation, no cardiac murmurs, no organomegaly on abdominal examination, and no stigmata of endocarditis on skin examination. Laboratory studies revealed a WBC count of 4600 cells/mL (normal range, 4800-11,000 cells/mL) with a normal differential; normal hemoglobin level and hematocrit; platelet count of 64,000 platelets/mL (normal range, 140,000-440,000 platelets/mL); prothrombin time of 10.8 s (normal range, 9.0-11.0 s); partial thromboplastin time of 28 s (normal range, 23.7-33. mal range, 0.4-2.0 mg/dL); and serum creatinine level of 1.1 mg/dL (normal range, 0.9-1.3 mg/dL). Blood cultures showed no growth, and thick and thin smears for malaria were unrevealing. Plain films of the chest demonstrated a right middle lobe infiltrate (figure 1), and CT of the abdomen with contrast demonstrated hepatomegaly. Serological testing was performed for viral hepatitis and cytomegalovirus; these demonstrated immunization against hepatitis B and past exposure to cytomegalovirus. A liver biopsy demonstrated numerous nonspecific granulomas without fibrin rings (figure 2). They were distributed in the midzonal region, were confined to the parenchyma, and did not satellite on either the central veins or the portal areas. The most characteristic lesion of Coxiella burnetii liver involvement, the fibrin-ring or "doughnut" granuloma, which is composed of a fat vacuole surrounded by a ring of fibrin, epithelioid cells, giant cells, and neutrophils [3] , was not appreciated. The patient defervesced after 72 h of therapy with piperacillin-tazobactam. He received a total of 8 days of piperacillin-tazobactam and was discharged with a 6-day course of levofloxacin.
When examined in the Infectious Diseases Clinic 8 weeks after onset of his illness, the patient had a mildly decreased energy level but was otherwise asymptomatic. Serum transaminase levels had returned to normal. Serological testing was performed for organisms known to cause fever and granulomatous hepatitis, including The patient received 1 month of doxycycline therapy. The results of subsequent serological testing suggested acute, resolved Q fever. The anti-phase II titer was the same or higher than the anti-phase I titer for serum samples tested at 3 other laboratories (table 1) . No circulating C. burnetii was detected via electrochemiluminescence assay and PCR [8] of blood samples tested at the United States Army Medical Research Institute for Infectious Diseases (Fort Detrick, MD). The serological test results obtained from a second laboratory that were negative for Brucella species (table 2), multiple sets of sterile cultures of blood obtained during the acute phase of illness, and the convincing Q fever serological test results led us to exclude the diagnosis of brucellosis.
Although he returned to his usual state of health by January 2004, the patient presented to the hospital in August 2004 with complaints of several months of sore throat, unrefreshing sleep, anhedonia, decreased energy, impaired concentration and short-term memory, decreased motivation at work, and dull bilateral hip aching. The results of a complete blood count, serum chemistry results, liver function test results, thyroid stimulating hormone level, erythrocyte sedimentation rate, and Creactive protein level were all within normal limits. The patient met the revised Centers for Disease Control and Prevention criteria for chronic fatigue syndrome and was offered cognitive behavioral therapy and treatment with antidepressants, both of which he declined. He did not meet Diagnostic and Statistical Manual of Mental Disorders IV criteria for major depressive disorder or post-traumatic stress disorder. His symptoms improved somewhat over a 6-month period with exercise. Case report 2. In September 2004, a 35-year-old male member of the US Air Force was admitted to our facility complaining of 4 days of fever, headache, myalgia, malaise, and anorexia and 1 day of loose stools. He had returned from a 3-month tour in Iraq ∼3 weeks prior to the onset of this illness. While in Iraq, the patient had remained within the base compound and had no notable food or animal exposures. He did report multiple mosquito and sand fly bites and had not taken the doxycycline prescribed for malaria prophylaxis. Upon returning to the United States, his activities included swimming in a lake, but there had been no recent camping or hunting. He had a pet dog and rabbit, both of which were healthy and not recently parturient. His wife had a self-limited febrile illness 1 week prior to his evaluation.
On physical examination, the patient had a temperature of 39.3ЊC and appeared to be mildly ill but had no localizing signs of infection. Pertinent negative findings included no adenopathy, no abnormalities on lung auscultation, no cardiac murmurs, no organomegaly on abdominal examination, and no stigmata of endocarditis on skin examination. Laboratory studies revealed a WBC count of 3900 cells/mL (normal range, 4000-14,000 cells/mL) with 76% neutrophils; normal hemoglobin and hematocrit; platelet count of 123,000 platelets/mL (normal range, 150,000-450,000 platelets/mL); erythrocyte sedimentation rate of 28 mm/h (normal range, 0-15 mm/h); prothrombin time of 14.6 s (normal range, 10.7-14. Multiple thick and thin smears for malaria, blood cultures, and stool cultures had negative results. Serological testing for leptospirosis, cytomegalovirus, Epstein-Barr virus, HIV, Bartonella species, Brucella species, and Leishmania species was performed. The patient received empirical therapy with ceftriaxone 2 g iv daily for a 7-day course, and his fever resolved within 48 h. The remainder of the patient's hospitalization was notable for transient, self-limited proteinuria (maximum 24-h urine protein, 1.7 g).
One week after discharge from the hospital, the patient remained afebrile. The results of urinalysis, a complete blood count, and liver function tests had normalized. The results of a B. abortus IgM ELISA were equivocal, and the patient initiated therapy with doxycycline and rifampin (he received a 1-month The results of serological testing at 2 other laboratories were consistent with acute Q fever, with significantly elevated anti-phase II titers and normal or minimally elevated anti-phase I titers. These results strongly suggest that this was a case of acute, resolved Q fever. Brucellosis was again excluded on the basis of negative serological test results obtained at 2 other laboratories (table 4) , sterile blood cultures, and compelling serological test results for Q fever.
Discussion. Q fever is a worldwide zoonotic disease caused by the rickettsial pathogen C. burnetii [9] . The reservoir for infection is broad and not fully known; it includes mammals, birds, and arthropods. The true incidence of infection is unclear and most likely underestimated. Humans frequently acquire the infection from sheep and cows via inhalation of aerosolized infectious material or the ingestion of contaminated milk products. This agent is highly infectious; a single organism can cause illness. C. burnetii infection is often subclinical or mild and is often self-limited. Common clinical presentations include a nonspecific febrile illness, atypical pneumonia, and hepatitis. Chronic infection can occur and most commonly involves the heart, arteries, liver, and bone.
Q fever has military relevance because of its potential as a bioterrorism agent and because of the risk for natural infection in deployed personnel. An unclassified report from the Defense Intelligence Agency in 1990 assessed the expected infectious disease threat of a short-duration military operation in northern Iraq [10] . It suggested that endemic Q fever posed a minor risk to military personnel under normal circumstances but might pose an increased threat to nonconventional forces. In 1991, the Defense Intelligence Agency reported that the results of tests performed on blood samples obtained from 21 of 130 Iraqi military personnel involved in the Persian Gulf War suggested previous exposure to C. burnetii [11] . The conclusion was that Q fever posed a relatively low risk to US personnel deploying to that region. The fact that only 3 cases of Q fever were reported in US troops involved in the Persian Gulf War [12, 13] seemed to confirm these analyses.
Recent data, however, suggest that Q fever may pose more of a threat to US forces in Iraq than previously thought. An epidemic of Q fever identified among soldiers from the Czech Republic serving in the United Nations Stabilization Force at 4 bases in Bosnia and Herzegovina in 1997 highlighted the possibility that personnel involved in nonconventional activities, such as prolonged peacekeeping missions, may be at increased risk, compared with personnel involved in short-term, conventional military operations [14] . Over a 2-month period, there were 14 symptomatic and 12 subclinical cases among 610 personnel (infection rate, 4.3%). A sheep farm with active lambing was located in close proximity to the base with the highest attack rate. The authors hypothesized that helicopter operations at a nearby landing zone may have generated infectious aerosols and, thus, been a cause of the outbreak.
Anderson and colleagues described 62 cases of pneumonia (19 severe cases and 43 nonsevere cases) in US Military members in Iraq between 1 March and 20 August 2003 [15, 16] . Eight patients (3 with severe cases and 5 with nonsevere cases) were found to have serological evidence suggesting C. burnetii as the etiologic agent. All 8 patients initially presented in Northern Iraq, the only region in the country suitable for grazing of livestock, rather than the nomadic herding common elsewhere. This led to the hypothesis that the larger concentrations of livestock in the northern areas might translate into a higher risk of transmission of C. brunetti to humans because of a higher chance of contact with infected animals. The 3 patients who presented with severe pneumonia had significant environmental exposures: all 3 patients reported close contact with animals (dogs, cats, sheep, goats, or camels), 2 reported tick bites within 30 days prior to onset of illness, and 1 reported ingestion of raw sheep's milk.
One of our patients reported significant environmental exposures, as well. His exposures were likely related to the fact that he was living in the community for 4 months. Along with the Czech epidemic in Bosnia and Herzegovina in 1997 and the cases of pneumonia among US forces in 2003, the 2 cases that we present here support the theory that Q fever poses an increased threat to nonconventional forces. We concur with the recommendation of Anderson et al. [16] that further studies are indicated, including serosurveys of military units with cases using stored serum samples obtained before and after deployment, a case-control study to assess the risk factors for Q fever in US forces in Iraq to allow development of effective prevention strategies, and a longitudinal study to evaluate the occurrence of chronic fatigue syndrome and long-term health sequelae. The diagnosis of Q fever is made primarily by serological testing results; immunofluorescence assay is currently the method of choice [17, 18] . Acute and chronic Q fever can be differentiated via serological testing results because of the antigenic shift or phase variation exhibited by C. burnetii. In acute infection, IgG and IgM anti-phase II antibody titers are elevated 1-2 weeks after the onset of infection; seroconversion occurs by the third week in 90% of cases. An IgG anti-phase II antibody titer of у1:200 and an IgM anti-phase II antibody titer ofу1:50 are considered to be suggestive of acute infection. In cases of chronic infection, the IgG anti-phase I antibodies are predominant, and titers of у1:800 are considered to be significant. Antibody titers generally peak 1-2 months after the onset of symptoms. The titers usually decrease gradually over the following year; IgM antibodies disappear first, but IgG titers may remain positive for years. Chronic infection is suggested when high levels of phase I antibodies persist.
Serological test results for each of our patients varied considerably among laboratories (even among those laboratories using the same test kit). Most notably, initial results from LabCorp suggested chronic infection with an anti-phase I titer elevated to a greater magnitude than the anti-phase II titer, whereas results from other laboratories demonstrated the opposite pattern, suggesting acute C. burnetii infection. In both cases, the B. abortus IgM ELISA results were falsely equivocal or positive, suggesting cross-reactivity with antibodies generated against C. burnetii.
In summary, Q fever poses more of a threat to US forces deployed in Iraq than was initially thought. Although it is important to suspect the diagnosis in the right clinical setting, a clinician must also have an understanding of the methodology and capabilities of the available tests and the laboratories to which specimens are submitted.
